Atlas Trials

Explorative Clinical Investigation to Investigate the Ability of PreciseInhale to Direct Regional Lung Targeting and Reduce the Degree of Throat Deposition and Subsequent Gastrointestinal Absorption in Healthy Volunteers After Inhalation of Test Drug Substances Via the PreciseInhale System

Clinical trial NCT04946630 · COMPLETED

Trial details

NCT number
NCT04946630
Sponsor
Inhalation Sciences Sweden AB
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Nebulizers and Vaporizers
Start date
2021-06-07
Primary completion
2021-07-22
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.